Hong Kong Pharma Digital Technology Holdings Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Hong Kong Pharma Digital Technology Holdings Limited (HKPD) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023
Period EndingDec 2025Mar 2024Mar 2023
Operating Activities
Net Income-0.031.331.00
Depreciation & Amortization1.070.930.71
Change in Working Capital-0.52-2.650.01
Change in Accounts Receivable-1.02-2.05-0.93
Change in Inventory0.38-0.74-0.19
Change in Accounts Payable0.400.090.98
Change in Other Working Capital-0.280.13-0.05
Other Operating Activities0.040.000.00
Net Cash from Operating Activities0.57-0.391.73
Investing Activities
Capital Expenditures-0.15-0.09-0.12
Purchases of Investments-2.300.000.00
Sales/Maturities of Investments0.00-0.040.00
Other Investing Activities-0.090.01-0.01
Net Cash from Investing Activities-2.45-0.04-0.13
Financing Activities
Debt Repayment-0.93-1.77-1.34
Common Stock Issued4.300.510.00
Other Financing Activities-1.38-0.350.00
Net Cash from Financing Activities2.000.54-1.16
Summary
Effect of Forex Changes on Cash0.010.000.00
Net Change in Cash0.120.100.44
Cash at Beginning of Period0.630.520.08
Cash at End of Period0.750.630.52
Free Cash Flow0.41-0.481.61
Supplemental Disclosures
Interest Paid0.100.080.06
Income Taxes Paid0.290.000.00